ACOTEC SCIEN.H. DL-00001 (F:7W3) — Stock Price
ACOTEC SCIEN.H. DL-00001 (F:7W3) is currently trading at €0.82 EUR, down 1.81% today. Over the past 52 weeks, shares have ranged between €0.81 and €1.61. This page tracks ACOTEC SCIEN.H. DL-00001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 7W3 market cap overview.
ACOTEC SCIEN.H. DL-00001 (7W3) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ACOTEC SCIEN.H. DL-00001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ACOTEC SCIEN.H. DL-00001 Income Statement — Revenue, Profit & Earnings by Year
ACOTEC SCIEN.H. DL-00001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €644.63 Million | €533.99 Million | €473.85 Million | €395.55 Million | €303.81 Million |
| Cost of Revenue | €168.32 Million | €131.27 Million | €96.43 Million | €59.19 Million | €37.87 Million |
| Gross Profit | €476.31 Million | €402.72 Million | €377.42 Million | €336.35 Million | €265.94 Million |
| Research & Development | €213.66 Million | €216.77 Million | €190.07 Million | €183.80 Million | €141.29 Million |
| SG&A | €182.33 Million | €157.71 Million | €181.32 Million | €160.51 Million | €158.02 Million |
| Total Operating Expenses | €539.48 Million | €497.09 Million | €452.29 Million | €395.61 Million | €330.48 Million |
| Operating Income | €105.16 Million | €36.90 Million | €21.56 Million | €-65.00K | €-26.66 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €9.38 Million | €9.90 Million | €9.83 Million | €1.42 Million | €3.82 Million |
| Income Before Tax | €122.18 Million | €52.60 Million | €14.45 Million | €70.32 Million | €-67.24 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €119.18 Million | €52.28 Million | €14.49 Million | €70.14 Million | €-79.08 Million |
ACOTEC SCIEN.H. DL-00001 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ACOTEC SCIEN.H. DL-00001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €1.87 Billion | €1.66 Billion | €1.61 Billion | €1.41 Billion | €1.31 Billion |
| Total Current Assets | €1.34 Billion | €1.21 Billion | €1.21 Billion | €1.26 Billion | €1.24 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €548.14 Million | €112.80 Million | €241.58 Million | — | — |
| Net Receivables | €220.49 Million | €161.10 Million | €143.64 Million | €131.91 Million | €44.21 Million |
| Inventory | €126.95 Million | €155.99 Million | €150.96 Million | €116.44 Million | €41.55 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €1.15 Million | €1.15 Million | €1.15 Million | €1.15 Million | €1.15 Million |
| Total Liabilities | €392.01 Million | €312.76 Million | €314.53 Million | €134.46 Million | €100.17 Million |
| Total Current Liabilities | €233.34 Million | €134.79 Million | €116.25 Million | €98.67 Million | €88.11 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €1.48 Billion | €1.35 Billion | €1.30 Billion | €1.28 Billion | €1.21 Billion |
| Retained Earnings | €-35.03 Million | €-131.93 Million | €-184.21 Million | €-198.69 Million | €-268.83 Million |
ACOTEC SCIEN.H. DL-00001 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ACOTEC SCIEN.H. DL-00001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €150.27 Million | €102.79 Million | €-12.88 Million | €-68.75 Million | €-10.48 Million |
| Capital Expenditures | €81.15 Million | €97.48 Million | €79.66 Million | €46.70 Million | €21.24 Million |
| Free Cash Flow | €69.12 Million | €5.31 Million | €-92.54 Million | €-115.45 Million | €-31.72 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | €323.08 Million |
| Stock-Based Compensation | €9.21 Million | €0.00 | €5.26 Million | €15.25 Million | €33.36 Million |
| Depreciation | €53.64 Million | €49.98 Million | €46.26 Million | €19.44 Million | €12.40 Million |
| Change in Cash | €-343.95 Million | €112.57 Million | €-355.31 Million | €-150.79 Million | €993.15 Million |
ACOTEC SCIEN.H. DL-00001 Earnings History — EPS Actual vs. Analyst Estimates
Track ACOTEC SCIEN.H. DL-00001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for ACOTEC SCIEN.H. DL-00001.